Alterity Therapeutics Ltd
ATH
Company Profile
Business description
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
Contact
350 Collins Street
Level 14
Melbourne VIC 3000
AUST: +61 393494906
E: info@pranabio.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
11
Stocks News & Analysis
stocks
Taxing unrealised super capital gains – is there a better idea?
The efficacy and fairness of establishing an unrealised gains tax regime will hopefully be hotly debated at the next election. We need better ideas on how to use the strategic and unique benefits of our massive super funds.
stocks
The market is underestimating this cheap ASX miner
The shares remain undervalued as we anticipate higher sales from lower-cost mines driving improved margins.
stocks
Undervalued ASX opportunity
The market is pessimistic and downplaying earnings stabilization at the ASX listed financial services firm.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,895.90 | 39.80 | -0.50% |
| CAC 40 | 7,978.51 | 43.48 | 0.55% |
| DAX 40 | 18,496.79 | 23.50 | 0.13% |
| Dow JONES (US) | 38,111.48 | 330.06 | -0.86% |
| FTSE 100 | 8,231.05 | 47.98 | 0.59% |
| HKSE | 18,230.19 | 246.82 | -1.34% |
| NASDAQ | 16,737.08 | 183.50 | -1.08% |
| Nikkei 225 | 38,054.13 | 502.74 | -1.30% |
| NZX 50 Index | 11,674.86 | 117.65 | 1.02% |
| S&P 500 | 5,235.48 | 31.47 | -0.60% |
| S&P/ASX 200 | 7,628.20 | 37.40 | -0.49% |
| SSE Composite Index | 3,091.68 | 19.34 | -0.62% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Peninsula Energy Ltd PEN | 0.12 | 0.01 | -4.17% |
| PYC Therapeutics Ltd PYC | 0.10 | 0.00 | 0.00% |
| Alumina Ltd AWC | 1.89 | 0.08 | 4.13% |
| Sayona Mining Ltd SYA | 0.04 | 0.00 | 2.44% |
| De Grey Mining Ltd DEG | 1.11 | 0.03 | 2.55% |
| South32 Ltd S32 | 3.97 | 0.03 | 0.76% |
| Catapult Group International Ltd CAT | 1.76 | 0.06 | 3.53% |
| Pilbara Minerals Ltd PLS | 3.83 | 0.03 | 0.79% |
| Red 5 Ltd RED | 0.44 | 0.00 | 0.00% |
| Telstra Group Ltd TLS | 3.45 | 0.01 | 0.15% |